Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Inhibition of SARS-CoV 3CL protease by flavonoids.

Tytuł:
Inhibition of SARS-CoV 3CL protease by flavonoids.
Autorzy:
Jo S; College of Pharmacy and Graduates School of Pharmaceutical Sciences, Ewha W. University, Seoul, Republic of Korea.
Kim S; College of Pharmacy and Graduates School of Pharmaceutical Sciences, Ewha W. University, Seoul, Republic of Korea.
Shin DH; College of Pharmacy and Graduates School of Pharmaceutical Sciences, Ewha W. University, Seoul, Republic of Korea.
Kim MS; College of Pharmacy and Graduates School of Pharmaceutical Sciences, Ewha W. University, Seoul, Republic of Korea.
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2020 Dec; Vol. 35 (1), pp. 145-151.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basingstoke, UK : Taylor & Francis, c2002-
MeSH Terms:
Antiviral Agents/*pharmacology
Enzyme Inhibitors/*pharmacology
Flavonoids/*pharmacology
Severe acute respiratory syndrome-related coronavirus/*drug effects
Viral Proteins/*antagonists & inhibitors
Antiviral Agents/chemical synthesis ; Antiviral Agents/chemistry ; Coronavirus 3C Proteases ; Cysteine Endopeptidases/isolation & purification ; Cysteine Endopeptidases/metabolism ; Dose-Response Relationship, Drug ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Flavonoids/chemical synthesis ; Flavonoids/chemistry ; Humans ; Molecular Structure ; Severe acute respiratory syndrome-related coronavirus/enzymology ; Structure-Activity Relationship ; Viral Proteins/isolation & purification ; Viral Proteins/metabolism
References:
PLoS One. 2011;6(11):e27228. (PMID: 22073294)
Protein Cell. 2013 Apr;4(4):248-50. (PMID: 23549610)
J Med Chem. 2006 Oct 19;49(21):6177-96. (PMID: 17034125)
J Med Chem. 2006 Jan 26;49(2):534-53. (PMID: 16420040)
N Engl J Med. 2003 May 15;348(20):1967-76. (PMID: 12690091)
Virus Res. 2015 Oct 2;208:56-65. (PMID: 26036787)
Spectrochim Acta A Mol Biomol Spectrosc. 2009 Sep 1;73(5):936-41. (PMID: 19501542)
Nat Prod Res. 2017 Feb;31(4):487-491. (PMID: 27295355)
Arch Virol. 2017 Sep;162(9):2539-2551. (PMID: 28547385)
Planta Med. 2014 Feb;80(2-3):177-82. (PMID: 24458263)
J Virol. 2012 Jul;86(14):7577-87. (PMID: 22553325)
Adv Virus Res. 1997;48:1-100. (PMID: 9233431)
Brain Res. 2009 Jan 23;1250:164-74. (PMID: 18992719)
Biochem Biophys Res Commun. 2005 Jul 22;333(1):194-9. (PMID: 15950190)
Emerg Infect Dis. 2005 Mar;11(3):417-24. (PMID: 15757557)
Bioorg Med Chem. 2010 Nov 15;18(22):7940-7. (PMID: 20934345)
Bioorg Med Chem Lett. 2006 Jun 15;16(12):3337-40. (PMID: 16621533)
Molecules. 2012 Sep 07;17(9):10774-90. (PMID: 22960870)
Acta Crystallogr D Biol Crystallogr. 2015 May;71(Pt 5):1102-11. (PMID: 25945576)
Sci Rep. 2017 Feb 03;7:41864. (PMID: 28157234)
Nat Rev Microbiol. 2016 Aug;14(8):523-34. (PMID: 27344959)
J Virol. 2013 Nov;87(21):11955-62. (PMID: 23986593)
Biotechnol Lett. 2012 May;34(5):831-8. (PMID: 22350287)
Lancet. 2003 May 24;361(9371):1761-6. (PMID: 12781533)
Biochem Biophys Res Commun. 2004 Jun 11;318(4):862-7. (PMID: 15147951)
Nat Prod Res. 2020 Mar;34(5):692-705. (PMID: 30445839)
Science. 2005 Oct 28;310(5748):676-9. (PMID: 16195424)
Proteins. 2004 May 1;55(2):351-67. (PMID: 15048827)
Contributed Indexing:
Keywords: FRET; SARS-CoV; SARS-CoV 3CLpro; flavonoid; inhibitory compounds
Substance Nomenclature:
0 (Antiviral Agents)
0 (Enzyme Inhibitors)
0 (Flavonoids)
0 (Viral Proteins)
EC 3.4.22.- (Cysteine Endopeptidases)
EC 3.4.22.28 (Coronavirus 3C Proteases)
Entry Date(s):
Date Created: 20191115 Date Completed: 20200113 Latest Revision: 20231020
Update Code:
20240105
PubMed Central ID:
PMC6882434
DOI:
10.1080/14756366.2019.1690480
PMID:
31724441
Czasopismo naukowe
There were severe panics caused by Severe Acute Respiratory Syndrome (SARS) and Middle-East Respiratory Syndrome-Coronavirus. Therefore, researches targeting these viruses have been required. Coronaviruses (CoVs) have been rising targets of some flavonoids. The antiviral activity of some flavonoids against CoVs is presumed directly caused by inhibiting 3C-like protease (3CLpro). Here, we applied a flavonoid library to systematically probe inhibitory compounds against SARS-CoV 3CLpro. Herbacetin, rhoifolin and pectolinarin were found to efficiently block the enzymatic activity of SARS-CoV 3CLpro. The interaction of the three flavonoids was confirmed using a tryptophan-based fluorescence method, too. An induced-fit docking analysis indicated that S1, S2 and S3' sites are involved in binding with flavonoids. The comparison with previous studies showed that Triton X-100 played a critical role in objecting false positive or overestimated inhibitory activity of flavonoids. With the systematic analysis, the three flavonoids are suggested to be templates to design functionally improved inhibitors.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies